Basic clinical features of the chronic hepatitis B patients
| Patients (n) | 256 | |
| Follow-up duration (years) | Total person-years | 1294.25 |
| Average/SD | 5.06/4.20 | |
| Median | 4.52 | |
| Max | 15.06 | |
| Minimum | 1.51 | |
| Sex, n (%) | Male | 181 (70.7) |
| Female | 75 (29.3) | |
| Age (years) | Mean (SD) | 45.7 (10.3) |
| Age (years) distribution, n (%) (256 patients total) | <30 | 26 (10.2) |
| 30–40 | 65 (25.4) | |
| 40–50 | 68 (26.6) | |
| 50–60 | 68 (26.6) | |
| >60 | 29 (11.3) | |
| HBeAg, n (%) (244 patients total had HBeAg data) | Positive | 77 (31.56) |
| Negative | 167 (68.44) | |
| HBeAb, n (%) (239 patients total had HBeAb data) | Positive | 170 (71.1) |
| Negative | 69 (28.9) | |
| HBeAg negative or HBeAb positive (247 patients total had HBeAg or HBeAb data) | 188 (76.1) | |
| BMI*, (kg/m2) (226 patients total) | Mean (SD) | 24.68 (3.81) |
| <18.5, n (%) | 6 (2.56) | |
| 18.5 to <25, n (%) | 125 (55.3) | |
| 25.0 to <30, n (%) | 78 (34.5) | |
| 30.0 or higher, n (%) | 17 (7.52) | |
| Initial FIB-4 index | Mean | 1.34 |
| SD | 0.25 | |
| Median | 1.07 | |
| Last FIB-4 index | Mean | 1.48 |
| SD | 0.03 | |
| Median | 1.22 | |
*The BMI is the weight in kilograms divided by the square of height in metres.
BMI, body mass index; FIB-4, Fibrosis-4 Index; HBeAb, hepatitis B antibody; HBeAg, hepatitis B e antigen.